A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
Phase of Trial: Phase I
Latest Information Update: 08 May 2017
At a glance
- Drugs LEO 130852A (Primary) ; Clobetasol
- Indications Skin disorders
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 12 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 26 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 21 Mar 2015 New trial record